Conception of peroral sustained-release dosage forms: calculation of initial and maintenance dose with consideration of accumulation
Förster, H.; Lippold, B.C.
Pharmaceutica Acta Helvetiae 57(12): 345-349
1982
ISSN/ISBN: 0031-6865 PMID: 7156173 Document Number: 190381
Document emailed within 1 workday
Related Documents
Lin, S.Y.; Yang, J.C. 1989: In-vitro dissolution behavior of some sustained-release theophylline dosage forms Pharmaceutica Acta Helvetiae 64(8): 236-240Trautlein, J.J.; Demers, L.; Esler, V.; Field, E. 1981: Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma Clinical Therapeutics 4(4): 252-262
Brock, M.H.; Dansereau, R.J.; Patel, V.S. 1994: Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms PharmacoTherapy 14(4): 430-437
Huynh-Ngoc, T.; Sirois Gérard 1977: Evaluation of a continuous fluid exchange system in the USP basket-stirrer dissolution test assembly. Part 11: Characterization of the dissolution profile of quinidine sustained-release dosage forms Journal de Pharmacie de Belgique 32(1): 67-75
Ritschel, W.A. 1973: Bioavailability of peroral dosage forms Bollettino Chimico Farmaceutico 112(3): 137-162
Frenkel', V.I. 1980: Rapid method of calculation of maintenance dose of cardiac glycosides Vrachebnoe Delo 5: 28-30
Imasaka, K.; Ueda, H.; Azuma, T.; Kawaguchi, T.; Nagai, T. 1989: Application of new silicone gel to sustained release dosage form of antitumor drug Drug Design and Delivery 4(3): 237-246
Hong, Y.-l.; Feng, Y.; Xu, D.-s. 2006: Study on index for formulation optimization of sustained or controlled released dosage forms Zhongguo Zhong Yao Za Zhi 31(1): 15-17
Ellis, C.N.; Fradin, M.S.; Hamilton, T.A.; Voorhees, J.J. 1995: Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy Archives of Dermatology 131(7): 791-795
Feldmann, E.G. 1986: Modified-release dosage forms American Journal of Hospital Pharmacy 43(10): 2565-2566
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
Gurny, R.; Buri, P.; Sucker, H.; Guitard, P.; Leuenberger, H. 1977: Production and theoretical development of dosage forms having release controlled by metacrylic films. 4. Multiple linear regression study of technological factors influencing the release of an active principle from microgranules encased by fluidization Pharmaceutica Acta Helvetiae 52(10): 247-251
Laicher, A.; Fuchs, W.S. 1998: Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline Arzneimittel-Forschung 48(5a): 540-547
Weiss, G.; Klemm, F.H.; Fuchs, W.S.; Stanislaus, F.; Zema, M.; Calanchi, M. 1998: Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension Arzneimittel-Forschung 48(5a): 604-612
Kenedi, P. 1986: Intraindividual dose-response relationship of sustained-release Elantan Zeitschrift für Kardiologie 75(Suppl 3): 77-79
Balant, L.P. 1993: Regulatory aspects of modified release dosage forms: clinical studies Bollettino Chimico Farmaceutico 132(5): 143-149
Sznitowska, M.łg.; Cal, K.; Kupiec, K. 2004: Development of modified-release dosage forms containing loratadine and pseudoephedrine sulfate Acta Poloniae Pharmaceutica 61 Suppl: 72-74
Siewert, M. 1993: Regulatory aspects of modified release dosage forms: in vivo/in vitro correlations Bollettino Chimico Farmaceutico 132(1): 10-22
2004: Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children Prescrire International 13(74): 203-206
Cosyns, P. 1974: A single daily dose of a sustained release form of amitriptyline in depressive illness Acta Psychiatrica Belgica 74(4): 430-436